Hrt Financial LP Stoke Therapeutics, Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$7.65 - $10.38 $297,141 - $403,179	-38,842 Reduced 35.87%	69,440 $578,000
Q4 2022 Feb 10, 2023	BUY	$7.07 - $15.69 $346,168 - $768,229	48,963 Added 82.54%	108,282 $999,000
Q3 2022 Nov 14, 2022	BUY	$12.56 - $22.53 $745,046 - $1.34 Million	59,319 New	59,319 $761,000
Q1 2022 May 16, 2022	SELL	$17.19 - $26.1 $310,399 - $471,287	-18,057 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$18.11 - $30.72 $327,012 - $554,711	18,057 New	18,057 $433,000

111

50M

63K

111K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $533M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.